Protective effects of rifampicin and its analog rifampicin quinone in a mice model of obesity-induced type 2 diabetes

Published: 17 March 2022| Version 1 | DOI: 10.17632/ndmp3wg864.1
Contributors:
Arnab Mukhopadhyay,

Description

Source data for the manuscript

Files

Institutions

National Institute of Immunology

Categories

Clinical Use of Antimicrobial Drugs, Rifamycins, Animal Diabetes

License